DJIA 16,954.11 -129.69 -0.76%
NASDAQ 4,445.31 -26.80 -0.60%
S&P 500 1,978.85 -9.13 -0.46%
market minute promo

49.62 -1.46 (-2.86%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

LGND $49.62 -2.86%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.65
Previous Close $51.08
Daily Range $49.52 - $51.16
52-Week Range $36.82 - $80.42
Market Cap $1.0B
P/E Ratio 108.68
Dividend (Yield) $0.00 (0.0%)
Volume 85,064
Average Daily Volume 395,327
Current FY EPS $1.06





Ligand Pharmaceuticals, Inc. (LGND) Description

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases. Website:

News & Commentary

2 Health Care Partnerships Go Head-To-Head

While the partnership between GlaxoSmithKline (NYSE: GSK) and Ligand (NASDAQ: LGND) seems to be moving forward, the partnership between Roche (OTCMKTS: RHHBY) and PDL (NASDAQ: PDLI) has seemingly reached its end

4 Biotech Stocks Breaking Out on Big Volume

Ligand Pharmaceuticals (LGND) in Focus: Stock Falls 6.7% - Tale of the Tape

Fed Says Districts Were Optimistic On Economic Outlook; Yahoo! Falls On Downbeat Results

Yahoo Falls On Downbeat Results; Time Warner Shares Spike Higher

Ligand Pharmaceuticals - The Bull Case

Ligand Pharmaceuticals: Appendix

Insider Trading Alert - GPS, HCN And LGND Traded By Insiders

Glaxo's Promacta in Phase III for MDS - Analyst Blog

Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog

Jeff Cooper: Will S&P Drop to 1,900 After Yesterday's Reversal?

A break below 1,937 implies a top of some degree in the index.

See More LGND News...

LGND's Top Competitors

LGND $49.62 (-2.86%)
Current stock: LGND
AMGN $122.28 (0.02%)
Current stock: AMGN
GILD $89.58 (-1.06%)
Current stock: GILD
BIIB $335.95 (-0.25%)
Current stock: BIIB